Full Text
Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

Abstract

Authors

R Lo Muto M Lenzi JM Franzini A Baggi G Bonetti A Hegenbarth

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×